Brasada Capital Management LP Has $1.53 Million Stake in HCP, Inc. (NYSE:HCP)

Brasada Capital Management LP increased its position in shares of HCP, Inc. (NYSE:HCP) by 36.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 42,812 shares of the real estate investment trust’s stock after buying an additional 11,479 shares during the period. Brasada Capital Management LP’s holdings in HCP were worth $1,525,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Hartford Investment Management Co. boosted its position in HCP by 0.5% during the third quarter. Hartford Investment Management Co. now owns 53,354 shares of the real estate investment trust’s stock worth $1,901,000 after purchasing an additional 282 shares during the period. Global Wealth Management Investment Advisory Inc. boosted its position in HCP by 18.6% during the second quarter. Global Wealth Management Investment Advisory Inc. now owns 1,882 shares of the real estate investment trust’s stock worth $60,000 after purchasing an additional 295 shares during the period. Parallel Advisors LLC boosted its position in HCP by 29.9% during the third quarter. Parallel Advisors LLC now owns 1,364 shares of the real estate investment trust’s stock worth $49,000 after purchasing an additional 314 shares during the period. Wetherby Asset Management Inc. boosted its position in HCP by 3.9% during the second quarter. Wetherby Asset Management Inc. now owns 8,918 shares of the real estate investment trust’s stock worth $285,000 after purchasing an additional 331 shares during the period. Finally, We Are One Seven LLC boosted its position in HCP by 1.4% during the third quarter. We Are One Seven LLC now owns 25,042 shares of the real estate investment trust’s stock worth $892,000 after purchasing an additional 345 shares during the period. Institutional investors and hedge funds own 95.80% of the company’s stock.

A number of equities analysts have commented on the stock. Morgan Stanley lifted their price objective on shares of HCP from $32.00 to $35.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 17th. Zacks Investment Research raised shares of HCP from a “hold” rating to a “buy” rating and set a $39.00 price objective for the company in a research report on Monday, October 14th. Argus raised shares of HCP from a “hold” rating to a “buy” rating in a research report on Tuesday, September 10th. KeyCorp lifted their price objective on shares of HCP from $34.00 to $37.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Finally, ValuEngine cut shares of HCP from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Two investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $36.78.

In other news, COO Thomas Klaritch sold 35,014 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total value of $1,261,204.28. Following the completion of the sale, the chief operating officer now owns 230,529 shares of the company’s stock, valued at $8,303,654.58. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.13% of the company’s stock.

Shares of HCP stock opened at $34.53 on Friday. The firm has a 50-day moving average of $36.24 and a 200-day moving average of $33.42. The stock has a market cap of $17.57 billion, a PE ratio of 18.97, a PEG ratio of 6.81 and a beta of 0.22. HCP, Inc. has a 52-week low of $26.58 and a 52-week high of $37.93. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.81 and a current ratio of 0.81.

HCP (NYSE:HCP) last announced its earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.43 by ($0.52). The business had revenue of $538.00 million during the quarter, compared to the consensus estimate of $503.65 million. HCP had a net margin of 43.66% and a return on equity of 12.78%. The company’s revenue was up 18.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.44 EPS. Equities research analysts predict that HCP, Inc. will post 1.75 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be given a $0.37 dividend. The ex-dividend date is Friday, November 1st. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.29%. HCP’s payout ratio is presently 81.32%.

HCP Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Further Reading: Quantitative Easing

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.